VICTHOM COMMENTS ON THE RECENT MARKET ACTIVITY
10 February 2011 - 9:30AM
PR Newswire (Canada)
QUEBEC, Feb. 9 /CNW/ -- QUEBEC, Feb. 9 /CNW Telbec/ - Victhom Human
Bionics Inc. ("Victhom" or the "Company", TSX-V: VHB) - At the
request of Market Surveillance, the Company wishes to comment on
the recent and unusual trading activity in its common shares.
The Company is not aware of any specific information not currently
disclosed which might explain the recent trading activity and
increase in the market price of its shares. However, the Company
would like to inform its investors that its partner, Ossur, during
its investors conference call held yesterday concurrent with the
release of its 2010 annual financial statements, reconfirmed the
information previously announced by the Company that the Power Knee
Second Generation would become commercially available in 2011. In
addition and as previously announced by Victhom in its Q-3 press
release, Neurostream Technologies, General Partnership has not yet
achieved a milestone as per the partnership agreement, a situation
that is dependent on a number of factors that are not entirely
under the Company's control. The Company's partner has continued to
fund Neurostream's operations on a voluntary basis. About Victhom
Victhom discovers, develops and manufactures bionic devices
involved in the treatment of a variety of physical and
physiological dysfunctions. Victhom Biotronix business developed
the Power Knee, the world's first and only motor-powered,
artificially intelligent prosthesis for above-knee amputees. The
Power Knee is commercialized by Ossur, a global leader in the
orthotics and prosthetics ("O&P") market. Victhom also has a
44.4% interest in Neurostream Technologies, General Partnership, a
joint venture with Otto Bock HealthCare, whose objective is to
bring to market the Neurostep(®) System, and to develop
neuromodulation products in other indications such as sleep apnea.
FORWARD-LOOKING STATEMENTS Some of the statements made herein may
constitute forward-looking statements. These statements relate to
future events or our future financial performance and involve known
and unknown risks, uncertainties and other factors that may cause
Victhom's actual results, performance or achievements to be
materially different from those expressed or implied by any of
Victhom's statements. Actual events or results may differ
materially. We disclaim any intention, and assume no obligation, to
update these forward-looking statements. Neither TSX Venture
Exchange nor its Regulation Services Provider (as that term is
defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release. To
view this news release in HTML formatting, please use the following
URL:
http://www.cnw.ca/en/releases/archive/February2011/09/c9426.html
table valign="top" border="0"trtd valign="top"
align="left"bSource:/b /td td valign="top" align="left"Victhom
Human Bionics Inc./td/tr trtd valign="top" align="left" /td td
valign="top" align="left" /td/tr trtd valign="top"
align="left"bFor more
information:/bb /bb /bb /bbr//td td valign="top"
align="left"Normand Rivardbr/ President & CEObr/ Victhom Human
Bionics Inc.br/ Tel.: 418-872-5665 ext 107br/ Fax:
418-872-6926br/ a
href="mailto:normand.rivard@victhom.com"inormand.rivard@victhom.com/i/a/td/tr
trtd /td td /td/tr trtd valign="top"
align="left" /td td valign="top" align="left"a
href="http://www.victhom.com/"iwww.victhom.com/i/a/td/tr/table
Copyright
Victhom Human Bionics Inc. (TSXV:VHB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Victhom Human Bionics Inc. (TSXV:VHB)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Victhom Human Bionics Inc. (TSX Venture Exchange): 0 recent articles
More Victhom Human Bionics Inc. News Articles